癌症后安全使用冷冻卵巢组织恢复生育力的策略:系统综述
本文系统综述了31项研究,涵盖五种旨在安全使用冷冻人卵巢组织恢复癌症后生育力的实验性策略:卵母细胞体外成熟、构建人工卵巢作为前窦卵泡再接种支架、清除污染恶性细胞的净化策略、异种移植卵母细胞成熟及基于干细胞的卵子发生;这些策略尚未进入临床试验阶段,需进一步研究以确定其风险与有效性。
要点
- 五种实验策略旨在避免卵巢组织自体移植 reintroducing 癌细胞。
- 所有策略仍处于实验阶段,尚未达到临床试验阶段。
- 进一步研究需确立风险与有效性,并讨论伦理问题。
核心结论
- 这些规避卵巢组织自体移植再引入癌细胞的策略正在开发中,但迄今为止尚未达到临床试验阶段。
- 需要进一步研究以确定其风险与有效性,同时相关伦理问题也需讨论。
- 尽管这些实验性程序仍在开发中,它们未来可能为肿瘤患者提供安全的生育力恢复选择。
研究设计与样本
- 系统综述,纳入31项研究。
主要发现
- 纳入研究涵盖五种实验策略:卵母细胞体外成熟;构建人工卵巢作为前窦卵泡再接种支架;清除污染恶性细胞的净化策略;异种移植卵母细胞成熟;基于干细胞的卵子发生。
局限性
- 这些策略尚未达到临床试验阶段。
- 需要进一步研究以确定其风险与有效性。
- 与这些策略相关的伦理问题也需要讨论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ovarian tissue cryopreservation and subsequent autotransplantation is a successful technique for fertility preservation in oncological patients. However, there are concerns regarding safety, as the graft may contain malignant cells that could lead to the reintroduction of cancer. To circumvent this problem several experimental strategies are being pursued. This systematic review was conducted to provide an overview of the strategies aiming to safely use cryopreserved human ovarian tissue to restore fertility after cancer. Thirty-one studies were included, covering five different experimental strategies: (i) in-vitro maturation of oocytes, (ii) constructing an artificial ovary as a scaffold for reseeding pre-antral follicles, (iii) purging strategies aimed at the eradication of contaminating malignant cells, (iv) maturation of oocytes by xenotransplantation, and (v) stem cell-based oogenesis. These strategies to circumvent the reintroduction of cancer cells through ovarian tissue autotransplantation are being developed, but so far have not reached the stage of clinical trials. Further research is required to establish their risks and effectiveness while the ethical aspects associated with these strategies also need to be discussed. Despite the fact that these experimental procedures are still under development, they might provide safe fertility restoration options for oncological patients in the future.
引用
- Eijkenboom L, Saedt E, Zietse C, et al. Strategies to safely use cryopreserved ovarian tissue to restore fertility after cancer: a systematic review. Reprod Biomed Online. 2022. PMID: 35945106. doi:10.1016/j.rbmo.2022.05.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。